• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[结直肠癌肝转移的家庭肝动脉灌注化疗临床研究]

[Clinical study of home hepatic arterial infusion chemotherapy for liver metastasis from colorectal cancer].

作者信息

Sato K, Takahashi T, Ashikaga K, Hanyu N, Aoki T

机构信息

Dept. of Surgery, Fuji Municipal Hospital.

出版信息

Gan To Kagaku Ryoho. 1996 Dec;23 Suppl 3:252-5.

PMID:8982310
Abstract

The clinical response and QOL were examined with 16 outpatients treated with home hepatic arterial infusion chemotherapy for liver metastasis from colorectal cancer. Fluorouracil 1,000 mg/body/week was administered by 5-hour intra-arterial infusion with a portable disposable pump. Six out of 8 who replied to a questionnaire survey led a their usual life during the treatment, and the average hospitalization period was only 7 days (including mortal cases). The clinical response was evaluated with 13 patients; 3 prophylactic treatment cases were excluded from the original 16 cases. The number of partial responses and no change were 3 and 7, respectively, and the overall response rate was 23.1%. These studies suggest that home hepatic arterial infusion chemotherapy is beneficial for patients with liver metastasis by improving their QOL.

摘要

对16例接受家庭肝动脉灌注化疗治疗结直肠癌肝转移的门诊患者的临床反应和生活质量进行了研究。使用便携式一次性泵通过5小时动脉内输注给予氟尿嘧啶1000mg/人/周。在回复问卷调查的8人中,有6人在治疗期间过着正常生活,平均住院时间仅为7天(包括死亡病例)。对13例患者进行了临床反应评估;最初的16例中排除了3例预防性治疗病例。部分缓解和病情稳定的病例数分别为3例和7例,总缓解率为23.1%。这些研究表明,家庭肝动脉灌注化疗通过改善生活质量对肝转移患者有益。

相似文献

1
[Clinical study of home hepatic arterial infusion chemotherapy for liver metastasis from colorectal cancer].[结直肠癌肝转移的家庭肝动脉灌注化疗临床研究]
Gan To Kagaku Ryoho. 1996 Dec;23 Suppl 3:252-5.
2
[Evaluation of intermittent hepatic arterial infusion chemotherapy for multiple liver metastasis of colorectal cancer].[结直肠癌多发肝转移的间歇性肝动脉灌注化疗评估]
Gan To Kagaku Ryoho. 1999 Oct;26(12):1721-4.
3
[Weekly hepatic arterial infusion of high dose 5-fluorouracil for liver metastasis from colorectal cancer].[每周肝动脉灌注大剂量5-氟尿嘧啶治疗结直肠癌肝转移]
Gan To Kagaku Ryoho. 1999 Oct;26(12):1718-20.
4
[Evaluation of the non-effective cases of irresectable multiple liver metastasis of colorectal cancer receiving hepatic arterial infusion chemotherapy].[接受肝动脉灌注化疗的不可切除性结直肠癌多发肝转移无效病例的评估]
Gan To Kagaku Ryoho. 1999 Oct;26(12):1725-8.
5
[Hepatectomy and intra-arterial infusion chemotherapy for hepatic metastasis of colorectal cancer].[肝切除术联合肝动脉灌注化疗治疗结直肠癌肝转移]
Gan To Kagaku Ryoho. 1997 Sep;24(12):1768-70.
6
[Hepatic arterial infusion of IL-2 and chemotherapy for unresectable liver metastasis from colorectal cancer].[肝动脉灌注白细胞介素-2联合化疗治疗不可切除的结直肠癌肝转移]
Gan To Kagaku Ryoho. 2002 Nov;29(12):2117-20.
7
Adjuvant hepatic arterial infusion chemotherapy after curative resection for Dukes C colorectal cancer: a pilot study.Dukes C期结肠癌根治性切除术后辅助性肝动脉灌注化疗:一项初步研究。
Hepatogastroenterology. 2004 Jan-Feb;51(55):124-7.
8
[Rules to carry out hepatic arterial infusion chemotherapy at home for patients with liver metastasis of colorectal cancer].[结直肠癌肝转移患者居家进行肝动脉灌注化疗的实施规则]
Gan To Kagaku Ryoho. 2002 Dec;29 Suppl 3:480-3.
9
[Complication due to arterial infusion chemotherapy for liver metastasis from colorectal cancer].[结直肠癌肝转移动脉灌注化疗所致并发症]
Gan To Kagaku Ryoho. 1997 Sep;24(12):1838-42.
10
[Effect of prophylactic intra-arterial infusion of anticancer drugs on post hepatic resection for hepatic metastasis of colorectal cancer].[预防性动脉内输注抗癌药物对结直肠癌肝转移肝切除术后的影响]
Gan To Kagaku Ryoho. 1994 Dec;21 Suppl 4:453-7.

引用本文的文献

1
Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility study.吉西他滨居家化疗对晚期非小细胞肺癌患者是安全且可接受的:一项可行性研究的结果
Br J Cancer. 2003 Dec 15;89(12):2190-6. doi: 10.1038/sj.bjc.6601420.